Its still pending because the likes of GSK who has input into the FDA put the word out to squash AMRN chances to survive and possibly pick them up on the cheap. Can you spell corruption ?????
All who don't jump in NOW will regret it big time when it goes to double digits. Garo is a master at building companies and selling them for mucho bucks, check his back round and what he did in the past.
He was good for one thing only diluting shareholders to pay for a drug that never had a chance. But he did accomplish one thing. He paid himself and the other bottom feeders big salaries while he made the shareholders believe DSCO had promise. He is the bottom of the bottom feeders.
You got that right. Cooper and the past CEOs are making a living of the shareholders that put up hard money because they were duped by these vermin.
After all he didn't pay for any of his shares he was granted options and now had his BOD re price them for the great job he has done for the shareholders... What a complete scam...
NO BOTTOM LINE EVER. One excuse after another. Even Sam Donaldson is complaining about the lack of earnings year after year. They have contracts up the gazoo but cannot bring a dime down to the bottom line. And no guidance. Never mind the company is not large enough to give guidance that does not hold water anymore.
They have more law suits against them than carter has liver pills. FDA paid for by big pharma GSK and the likes.......
I will do the same for your pumping post: SEC Enforcement will be notified of this:
johnamkins • Mar 17, 2015 8:24 AM Flag
users liked this posts
users disliked this posts
The FDA approval process is long and slow, IMO by the summer IMUC will be up in price 2-3 times. Don't let the shorts steal your shares. Good things come to those who wait. GLL
of dollars on the backs of diluted shareholder value over the past 15 years. The are so inept they did not do their DD on the market for the drug which is at best a non event in the industry. It is a piggy bank for these losers to milk a public company because they could not get a job in the private sector. Remember the former CEO who gave is wife a 100K contract to write a report on the companies drug. What a scam. After having Surfaxin approved they have less sales than a paper route. Does that tell you what these clowns are all about a big ZERO. Now they are looking for a bailout from someone to sell the garbage product who no one wants. I think they know their employment is history that is the reason for repricing the options for a job well done you pathetic scammers.
so we can avoid to invest in that company like the plague. What a worthless fool. And he draws over half a million dollars a year FOR WHAT????
Probably Hamburg tipped off hubby of pending approval and his hedge fund dirt bags bought in heavy. You know everything is on the up and up with this govt. Just look at the top
Another worthless lib. Her and hubby should return all of the money they earned for screwing the shareholders of various biotech companies...
AMRN is going back into the teens
AGEN has the hottest property in the market today. Bristol Meyers just got approved for a multibillion dollar drug for its check point inhibitor drug. Agen has the platform and also the best adjuvant in the industry QS21 which will bring in millions in royalties soon. Here is the article today: Opdivo belongs to a highly promising new class of medicines called PD-1 inhibitors that work by blocking a mechanism tumors use to hide from the immune system, allowing it to recognize and attack cancer cells.